Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News GE Healthcare’s ABUS technology shows dense breast imaging benefits

GE Healthcare’s ABUS technology shows dense breast imaging benefits

5th October 2016

GE Healthcare has announced new clinical trial results showing the benefits its Automated Breast Ultrasound (ABUS) technology can offer in the imaging of dense breast tissue.

The European Asymptomatic Screening Study aimed to evaluate the impact of ABUS in conjunction with full field digital screening mammography in 1,668 women aged 40 to 74 with dense breasts.

A 57 percent relative increase in breast cancer detection in dense breast tissue – or 6.6 cancers detected per 1,000 women screened – was associated with the ABUS technology, compared with 4.2 cancers per 1,000 women when using mammography alone.

As such, the results support the idea that using ABUS as part of a national screening programme in dense breasts would allow more cancers to be detected at an earlier stage.

Dr Brigitte Wilczek, lead researcher on the ABUS study, said: "The study shows that it is feasible to implement 3D ABUS into a high-volume mammography centre and increase the cancer detection rate, while maintaining an acceptable low recall rate."

Dense breast tissue is linked with an increase in the risk of developing cancer and also makes detecting cancer more difficult, because tumours and dense breast tissue appear alike in the mammogram images. By contrast, ultrasound technology allows the two to be clearly differentiated.

With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.ADNFCR-8000103-ID-801826381-ADNFCR

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.